|
1
|
Murakami M and Kudo I: Recent advances in
molecular biology and physiology of the prostaglandin
E2-biosynthetic pathway. Prog Lipid Res. 43:3–35. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Herschman HR: Prostaglandin synthase 2.
Biochim Biophys Acta. 1299:125–140. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ristimäki A, Sivula A, Lundin J, Lundin M,
Salminen T, Haglund C, Joensuu H and Isola J: Prognostic
significance of elevated cyclooxygenase-2 expression in breast
cancer. Cancer Res. 62:632–635. 2002.PubMed/NCBI
|
|
5
|
Rozic JG, Chakraborty C and Lala PK:
Cyclooxygenase inhibitors retard murine mammary tumor progression
by reducing tumor cell migration, invasiveness and angiogenesis.
Int J Cancer. 93:497–506. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Swami S, Krishnan AV, Moreno J,
Bhattacharyya RB, Peehl DM and Feldman D: Calcitriol and genistein
actions to inhibit the prostaglandin pathway: Potential combination
therapy to treat prostate cancer. J Nutr. 137(Suppl 1): S205–S210.
2007.
|
|
7
|
Subbaramaiah K and Dannenberg AJ:
Cyclooxygenase 2: A molecular target for cancer prevention and
treatment. Trends Pharmacol Sci. 24:96–102. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
AliFehmi R, Morris RT, Bandyopadhyay S,
Che M, Schimp V, Malone JM Jr and Munkarah AR: Expression of
cyclooxygenase-2 in advanced stage ovarian serous carcinoma:
Correlation with tumor cell proliferation, apoptosis, angiogenesis
and survival. Am J Obstet Gynecol. 192:819–825. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ranger GS, Thomas V, Jewell A and Mokbel
K: Elevated cyclooxygenase-2 expression correlates with distant
metastases in breast cancer. Anticancer Res. 24:2349–2351.
2004.PubMed/NCBI
|
|
10
|
Eberhart CE, Coffey RJ, Radhika A,
Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of
cyclooxygenase 2 gene expression in human colorectal adenomas and
adenocarcinomas. Gastroenterology. 107:1183–1188. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sinicrope FA, Lemoine M, Xi L, Lynch PM,
Cleary KR, Shen Y and Frazier ML: Reduced expression of
cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal
cancers relative to sporadic cancers. Gastroenterology.
117:350–358. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ristimäki A, Jaatinen R and Ritvos O:
Regulation of prostaglandin F2 alpha receptor expression in
cultured human granulosa-luteal cells. Endocrinology. 138:191–195.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zimmermann KC, Sarbia M, Weber AA,
Borchard F, Gabbert HE and Schrör K: Cyclooxygenase-2 expression in
human esophageal carcinoma. Cancer Res. 59:198–204. 1999.PubMed/NCBI
|
|
14
|
Heinonen PK and Metsä-Ketelä T:
Prostaglandin and thromboxane production in ovarian cancer tissue.
Gynecol Obstet Invest. 18:225–229. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Parida S and Mandal M: Inflammation
induced by human papillomavirus in cervical cancer and its
implication in prevention. Eur J Cancer Prev. 23:432–448. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Banno K, Iida M, Yanokura M, Irie H,
Masuda K, Kobayashi Y, Tominaga E and Aoki D: Drug repositioning
for gynecologic tumors: A new therapeutic strategy for cancer.
Scientific World Journal. 2015:3413622015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Braunschweig T, Chung JY and Hewitt SM:
Tissue microarrays: Bridging the gap between research and the
clinic. Expert Rev Proteomics. 2:325–336. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oberländer M, Alkemade H, Bünger S, Ernst
F, Thorns C, et al: A ‘waterfall’ transfer-based workflow for
improved quality of tissue microarray construction and processing
in breast cancer research. Pathol Oncol Res. 20:719–726. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.(In German). PubMed/NCBI
|
|
20
|
Dursun P, Yuce K, Usubutun A and Ayhan A:
Cyclooxygenase-2 expression in cervical intraepithelial neoplasia
III and squamous cell cervical carcinoma, and its correlation with
clinicopathologic variables. Int J Gynecol Cancer. 17:164–173.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Manchana T, Triratanachat S, Sirisabya N,
Vasuratna A, Termrungruanglert W and Tresukosol D: Prevalence and
prognostic significance of COX-2 expression in stage IB cervical
cancer. Gynecol Oncol. 100:556–560. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim HJ, Wu HG, Park IA and Ha SW: High
cyclooxygenase-2 expression is related with distant metastasis in
cervical cancer treated with radiotherapy. Int J Radiat Oncol Biol
Phys. 55:16–20. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim JJ, Wang J, Bambra C, Das SK, Dey SK
and Fazleabas AT: Expression of cyclooxygenase-1 and −2 in the
baboon endometrium during the menstrual cycle and pregnancy.
Endocrinology. 140:2672–2678. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ryu HS, Chang KH, Yang HW, Kim MS, Kwon HC
and Oh KS: High cyclooxygenase-2 expression in stage IB cervical
cancer with lymph node metastasis or parametrial invasion. Gynecol
Oncol. 76:320–325. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pyo H, Kim YB, Cho NH, Suh CO, Park TK,
Yun YS and Kim GE: Coexpression of cyclooxygenase-2 and thymidine
phosphorylase as a prognostic indicator in patients with FIGO stage
IIB squamous cell carcinoma of uterine cervix treated with
radiotherapy and concurrent chemotherapy. Int J Radiat Oncol Biol
Phys. 62:725–732. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ferrandina G, Lauriola L, Distefano MG,
Zannoni GF, Gessi M, Legge F, Maggiano N, Mancuso S, Capelli A,
Scambia G and Ranelletti FO: Increased cyclooxygenase-2 expression
is associated with chemotherapy resistance and poor survival in
cervical cancer patients. J Clin Oncol. 20:973–981. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ferrandina G, Lauriola L, Zannoni GF,
Distefano MG, Legge F, Salutari V, Gessi M, Maggiano N, Scambia G
and Ranelletti FO: Expression of cyclooxygenase-2 (COX-2) in tumour
and stroma compartments in cervical cancer: Clinical implications.
Br J Cancer. 87:1145–1152. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim HJ, Sohn TS, Lee KT, Lee JK, Paik SW
and Rhee JC: Expression of cyclooxygenase-2 and its correlation
with clinicopathologic factors of ampulla of vater cancer. J Korean
Med Sci. 18:218–224. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen YJ, Wang LS, Wang PH, Lai CR, Yen MS,
Ng HT and Yuan CC: High cyclooxygenase-2 expression in cervical
adenocarcinomas. Gynecol Oncol. 88:379–385. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Giordano G, D'Adda T, Dal Bello B, Brigati
F, Bersiga A, Campanini N, Berretta R, Rocco A and Merisio C:
Clinicopathologic implications of the epidermal growth factor
receptor, cyclooxygenase 2 expression and human papillomavirus
status in squamous cell carcinoma of the uterine cervix in the
elderly. Int J Gynecol Cancer. 21:337–348. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khunamornpong S, Settakorn J, Sukpan K,
Srisomboon J, Ruangvejvorachai P, Thorner PS and Siriaunkgul S:
Cyclooxygenase-2 expression in squamous cell carcinoma of the
uterine cervix is associated with lymph node metastasis. Gynecol
Oncol. 112:241–247. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang W, Jia HL, Huang JM, Liang YC, Tan H,
Geng HZ, Guo LY and Yao SZ: Identification of biomarkers for lymph
node metastasis in early-stage cervical cancer by tissue-based
proteomics. Br J Cancer. 110:1748–1758. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Settakorn J, Khunamornpong S, Sukpan K,
Srisomboon J and Siriaungkul S: Cyclooxygenase-2 expression in
cervical squamous cell carcinoma: The significance of expression in
neoplastic cells within the lymphovascular space. Asian Pac J
Cancer Prev. 10:1011–1014. 2009.PubMed/NCBI
|
|
34
|
Bandyopadhyay R, Chatterjee U, Mondal SK,
Nag D and Sinha SK: A study on expression pattern of
cyclooxygenase-2 in carcinoma of cervix. Indian J Pathol Microbiol.
54:695–699. 2011.PubMed/NCBI
|
|
35
|
Kim JH and Kim SJ: Overexpression of
microRNA-25 by withaferin A induces cyclooxygenase-2 expression in
rabbit articular chondrocytes. J Pharmacol Sci. 125:83–90. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ferrandina G, Ranelletti FO, Legge F,
Lauriola L, Poerio A, Zannoni GF, Smaniotto D, Margariti PA,
Macchia G and Scambia G: Cyclooxygenase-2 (COX-2) expression in
locally advanced cervical cancer patients undergoing chemoradiation
plus surgery. Int J Radiat Oncol Biol Phys. 55:21–27. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lindström AK, Tot T, Stendahl U, Syrjänen
S, Syrjänen K and Hellberg D: Discrepancies in expression and
prognostic value of tumor markers in adenocarcinoma and squamous
cell carcinoma in cervical cancer. Anticancer Res. 29:2577–2578.
2009.PubMed/NCBI
|
|
38
|
Gaffney DK, Holden J, Davis M, Zempolich
K, Murphy KJ and Dodson M: Elevated cyclooxygenase-2 expression
correlates with diminished survival in carcinoma of the cervix
treated with radiotherapy. Int J Radiat Oncol Biol Phys.
49:1213–1217. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Robert Koch Institute. Neue Daten zu Krebs
in Deutschland. http://www.rki.de/DE/Content/Service/Presse/Pressemitteilungen/2015/11_2015.htmlAccessed.
July 1–2016, (In German).
|
